Hépato-Gastro & Oncologie Digestive
Volume 29, issue 2, February 2022
Special feature: Foreign bodies in the gastrointestinal tract
Volume 29, issue 2, February 2022
ÉDITORIAL
Last advice before demolition
(p.151-2)
Hakim Bécheur
Free Access
MINI-REVUES
Left-sided portal hypertension: A rare and fatal entity
(p.155-63)
Pierre Mayer, Emanuele Felli, Aïna Venkatasamy
Faecal immunochemical tests: Resembling a Swiss army knife
(p.165-80)
Bernard Denis, Laurianne Plastaras, Callum G. Fraser
New nutritional therapies in Crohn's disease. What can we learn from the paediatric experience?
(p.183-90)
Rémi Duclaux-Loras, Nicolas Caron, Gilles Boschetti, Noël Peretti, Alain Lachaux
Biliary duct tumors:What is the place of percutaneous biliary drainage?
(p.192-202)
Badr Boutakioute, Raphaël Amar, Hajar El Mortaji, Dominique Cabral, Norbert Zhang, Robert Carlier, Frédérick Moryoussef, Mostafa El Hajjam
Gastro-intestinal cancers and thrombosis: A new place for direct oral anticoagulants?
(p.204-8)
Alice Ballerie, Alain Lescoat, Nicolas Belhomme, Marie Bismut, Pierre Guéret, Isabelle Gouin-Thibault, Patrick Jégo
Biobetter: A bet for the future
(p.209-12)
Thomas Bazin
Dossier thématique : Corps étrangers digestifs
Pré-test QCM
(p.215-6)
Mise au point
Foreign bodies of the upper and lower digestive tract
(p.217-25)
Vincent Quentin
Cas clinique
Ingestion of battery: do not be quiet!
(p.226-32)
Jérôme Viala
Revue bibliographique
Better understand and manage foreign bodies in the upper digestive tract
(p.233-6)
Lucille Quénéhervé
Entretien avec l'expert
Management of foreign bodies in the gastrointestinal tract
(p.237-41)
Xavier Dray
Post-test QCM
(p.242-4)
CONCEPTS ET PRATIQUE
Finally a second line in cholangiocarcinoma with the ABC-06 study: Oxaliplatin after cisplatin, a winning team!
(p.245-50)
Vincent Verdier, David Sefrioui
IBD and infliximab: Is it the end of proactive therapeutic drug monitoring?
(p.251-4)
Clément Bresteau, Mathieu Uzzan
Metabolic syndrome and risk of pancreatic cancer: It's good to lose weight but it is better not to take it!
(p.255-9)
Louis de Mestier, Vinciane Rebours
Lanifibranor, a pan-PPAR agonist, improves NASH lesions
(p.260-4)
Alexandre Pariente
Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis : need for better results !
(p.265-8)
Antoine Debourdeau, Jérémie Jacques
LECTURE
State of the art in Pancreatology
(p.269-70)
Louis de Mestier
BRÈVE D’HISTOIRE
The medical kit
(p.271-4)
Jean-Louis Payen
INJECTIONS DE RAPPEL
A retenir du no 1 janvier 2022
(p.275-8)